Connection

Raymond DuBois to Sulfonamides

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Sulfonamides.
Raymond DuBois
Connection Strength
1.602
Sulfonamides
  1. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014 Dec; 32(6):1105-1112.
    View in: PubMed
    Score: 0.446
  2. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs. Cancer Prev Res (Phila). 2009 Apr; 2(4):285-7.
    View in: PubMed
    Score: 0.308
  3. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
    View in: PubMed
    Score: 0.278
  4. Cyclooxygenase-2 selective inhibitors and prostate cancer: what is the clinical benefit? J Clin Oncol. 2006 Jun 20; 24(18):2691-3.
    View in: PubMed
    Score: 0.254
  5. The COX-2 story: is any drug completely "safe?". Gastroenterology. 2006 Jan; 130(1):6.
    View in: PubMed
    Score: 0.246
  6. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
    View in: PubMed
    Score: 0.055
  7. Cyclooxygenase-2-mediated DNA damage. J Biol Chem. 2005 Aug 05; 280(31):28337-46.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.